Understanding the Safety Profile of Ozambik: Updates on Intestinal Obstruction and Weight Loss Effects
2023-10-02 07:32:00 After its widespread use, and after gaining widespread fame for its clear results in weight loss, the US Food and Drug Administration (FDA) decided to update the label for the diabetes drug “Ozambik” and acknowledge reports of cases of intestinal obstruction among some of its users. This drug, which is usually used to … Read more